Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

656 studies match

clinicaltrialsPublishedShowing 51–100 of 656 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01562028	BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)(BELIEF)	completed	Phase 2	109	ETOP IBCSG Partners FoundationNETWORK	8	Aug 26, 2026	clinicaltrials
NCT03133546	Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M(BOOSTER)	completed	Phase 2	155	ETOP IBCSG Partners FoundationNETWORK	6